These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5827348)

  • 21. [Cytocidal effect of HH07A, a derivative of hainanensine, on L1210 cells in vitro].
    Ye YM; Xu CX; Guo JY; Cui GJ
    Yao Xue Xue Bao; 1995; 30(7):491-4. PubMed ID: 7484156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmentation of hematoporphyrin uptake and in vitro-growth inhibition of L1210 leukemia cells by succinylacetone.
    Ebert PS; Hess RA; Tschudy DP
    J Natl Cancer Inst; 1985 Mar; 74(3):603-8. PubMed ID: 3856064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental conditions favorable for tumor progression in peritoneal cavity induced by peritoneal cells without tumor selectivity.
    Segawa K; Ueno Y; Kataoka T
    Jpn J Exp Med; 1989 Jun; 59(3):127-33. PubMed ID: 2681889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substituted 2-acylpyridine-alpha-(N)-hetarylhydrazones as inhibitors of ribonucleotide reductase activity and L1210 cell growth.
    Cory JG; Downes DL; Cory AH; Schaper KJ; Seydel JK
    Anticancer Res; 1994; 14(3A):875-9. PubMed ID: 8074487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
    Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
    Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes of thymocyte subpopulations induced by activities diffusing from leukemia L1210 cells.
    Kawiak J; Kawalec M; Hoser G; Miks B; Skórski T; Pojda Z; Skurzak H
    Thymus; 1991 Nov; 18(3):185-92. PubMed ID: 1785132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity of antitumor agents toward cultured murine leukemia L1210 cells under a serum-deprived apoptotic condition.
    Kasamatsu T; Kohda K; Kawazoe Y
    Anticancer Res; 1995; 15(6B):2597-600. PubMed ID: 8669831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of a viral inhibitor produced with nucleic acids of normal and tumor tissue extracts].
    De Kohan SS; De la Peña NC; De Holstein BA; De Pirosky RR; De Lustig ES
    C R Seances Soc Biol Fil; 1969 May; 162(11):2026-7. PubMed ID: 4241376
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.
    Ross W; Rowe T; Glisson B; Yalowich J; Liu L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5857-60. PubMed ID: 6094001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice.
    Stern AM; Abeles RH; Tashjian AH
    Cancer Res; 1984 Dec; 44(12 Pt 1):5614-8. PubMed ID: 6498822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of benzohydroxamic acids on L1210 lymphoid leukemia cell nucleic acid metabolism.
    Hall IH; Taylor K; Izydore RA; Daniels DL
    Pharmazie; 1998 Nov; 53(11):794-9. PubMed ID: 9853360
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL; Wu MS; Chen Z
    Acta Pharmacol Sin; 2002 Oct; 23(10):946-51. PubMed ID: 12370101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
    Li LH; Olin EJ; Buskirk HH; Reineke LM
    Cancer Res; 1970 Nov; 30(11):2760-9. PubMed ID: 5487063
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
    Hilton J
    Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 7-R-O-methylnogarol (menogaril) on L1210 cell progression in vitro and in vivo.
    Adams EG; Bhuyan BK
    Cancer Res; 1986 Dec; 46(12 Pt 1):6125-30. PubMed ID: 2946401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of material from living cells by means of an insoluble trypsin derivative and deoxyribonuclease I.
    Kawalec M
    Folia Histochem Cytochem (Krakow); 1974; 12(3-4):281-9. PubMed ID: 4455577
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of camphoramine chloroacetic platinum (CCP) on biomacromolecules in L1210 leukemic cells].
    Wang LG; Liu XM; Ji XJ
    Yao Xue Xue Bao; 1987 Feb; 22(2):87-92. PubMed ID: 3618241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.